Experimental post-cancer treatment 'promising'

An experimental vaccine derived from tiny bits of tumour protein and involving a simple pinprick of the patient may prevent cancer from recurring, researchers believe.

Experimental post-cancer treatment 'promising'

An experimental vaccine derived from tiny bits of tumour protein and involving a simple pinprick of the patient may prevent cancer from recurring, researchers believe.

Early results in 14 vaccinated survivors of advanced breast cancer have shown promise, according to researcher Dr George Peoples Jr of Walter Reed Army Medical Centre.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited